Henry Morgan Net Worth

The estimated Net Worth of Henry Morgan is at least $4.83 million dollars as of 6 June 2014. Henry Morgan owns over 15,000 units of Biospecifics Technologies stock worth over $2,850,046 and over the last 15 years Henry sold BSTC stock worth over $1,976,016.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Henry Morgan BSTC stock SEC Form 4 insiders trading

Henry has made over 12 trades of the Biospecifics Technologies stock since 2009, according to the Form 4 filled with the SEC. Most recently Henry exercised 15,000 units of BSTC stock worth $12,450 on 6 June 2014.

The largest trade Henry's ever made was exercising 40,000 units of Biospecifics Technologies stock on 21 May 2014 worth over $40,000. On average, Henry trades about 13,902 units every 126 days since 2009. As of 6 June 2014 Henry still owns at least 32,193 units of Biospecifics Technologies stock.

You can see the complete history of Henry Morgan stock trades at the bottom of the page.

What's Henry Morgan's mailing address?

Henry's mailing address filed with the SEC is PO BOX 499,, 11 DOGWOOD ROAD, HOPE, NJ, 07844.

Insiders trading at Biospecifics Technologies

Over the last 33 years, insiders at Biospecifics Technologies have traded over $67,860,045 worth of Biospecifics Technologies stock and bought 7,761,661 units worth $656,708,120 . The most active insiders traders include Capital Management, Llc Kol..., International Plc Endo et Max Link. On average, Biospecifics Technologies executives and independent directors trade stock every 73 days with the average trade being worth of $6,538,649. The most recent stock trade was executed by International Plc Endo on 2 December 2020, trading 7,344,955 units of BSTC stock currently worth $650,028,518.

What does Biospecifics Technologies do?

Complete history of Henry Morgan stock trades at Biospecifics Technologies

Biospecifics Technologies executives and stock owners

Biospecifics Technologies executives and other stock owners filed with the SEC include:

• Jennifer Chao,
  Independent Chairman of the Board
• Michael Schamroth,
  Independent Director
• Paul Gitman,
  Independent Director
• Mark Wegman,
  Director
• Toby Wegman,
  Director
• Sarah McCabe,
  Stern Investor Relations
• Michael Sherman,
  Independent Director
• Corey Fishman,
  Independent Director
• Alex Monteith,
  Senior Vice President and Chief Business Officer
• Patrick Hutchison,
  Chief Financial Officer
• Joseph Truitt,
  Chief Executive Officer, Director
• Jeffrey Kenneth Vogel,
  
• Jyrki Mattila,
  Director
• Thomas Wegman,
  President
• Of Edwin H. Wegman Estate,
  10% owner
• Patrick M Caldwell,
  Principal Financial Officer
• Partners Lp Bio,
  10% owner
• Albert Horcher,
  
• Lawrence Dobroff,
  CFO
• Max Link,
  Director
• Henry Morgan,
  Director
• George M Gould,
  Director
• Matthew Geller,
  Director
• Capital Management, Llc Kol...,
  
• Capital Management, Llcra C...,
  
• Capital Management, Llcaldr...,
  
• Capital Management, Llc Kol...,
  
• Capital Management, Llcra C...,
  
• J Kevin Buchi,
  Chief Executive Officer
• International Plc Endo,
  10% owner